gip1 vs glp 1 Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease—State of the Art Science Behind GLP 1 GIP

Research priorities now, include adequately powered randomised controlled trials (stratified by obesity status), mechanistic studies linking mucosal GLP-1 signalling to clinical endpoints and longer-term safety surveillance

The efficacy of tirzepatide has generated interest in the development of further multi-receptor agonists that may provide enhanced therapeutic advantages while preserving good safety profiles (Sinha et al

Anyone injecting a product from the internet risks infections, incorrect placement, tissue damage, allergic reactions and other complications

Myoglobin is toxic to kidneys and can cause acute kidney injury or failure